CN Stock MarketDetailed Quotes

China National Accord Medicines Corporation (000028)

Watchlist
  • 26.05
  • -0.46-1.74%
Market Closed Apr 17 15:00 CST
14.50BMarket Cap12.76P/E (TTM)

China National Accord Medicines Corporation (000028) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
Total operating revenue
-1.29%73.42B
-2.38%55.12B
-2.62%36.8B
-4.17%18.29B
-1.46%74.38B
-0.21%56.47B
-1.57%37.79B
2.16%19.09B
2.77%75.48B
3.61%56.59B
Operating revenue
-1.29%73.42B
-2.38%55.12B
-2.62%36.8B
-4.17%18.29B
-1.46%74.38B
-0.21%56.47B
-1.57%37.79B
2.16%19.09B
2.77%75.48B
3.61%56.59B
Other operating revenue
-9.31%637.52M
----
-15.25%350.49M
----
11.00%703M
----
8.14%413.53M
----
-14.71%633.35M
----
Total operating cost
-1.65%71.81B
-2.73%53.87B
-2.88%35.96B
-4.01%17.88B
-0.35%73.02B
0.73%55.38B
-0.60%37.02B
2.54%18.63B
2.76%73.28B
3.41%54.98B
Operating cost
-0.84%65.58B
-1.95%49.34B
-2.31%32.86B
-3.62%16.4B
-0.45%66.13B
0.56%50.33B
-0.87%33.64B
2.80%17.02B
2.96%66.43B
3.53%50.05B
Operating tax surcharges
-1.75%186.31M
-2.14%138.89M
-2.74%93.37M
-1.70%44.71M
0.77%189.63M
2.00%141.93M
6.00%96M
6.61%45.48M
-2.14%188.18M
-2.31%139.15M
Operating expense
-9.58%4.85B
-9.87%3.55B
-7.78%2.44B
-7.26%1.17B
0.65%5.36B
2.52%3.94B
1.47%2.64B
0.11%1.26B
1.01%5.33B
2.58%3.84B
Administration expense
-6.80%1B
-9.09%703.4M
-8.46%466.64M
-12.28%220.75M
-2.88%1.07B
-4.39%773.75M
-3.94%509.77M
-5.12%251.65M
-2.03%1.11B
3.49%809.31M
Financial expense
-23.58%182.96M
-34.48%119.93M
-30.91%83.18M
-16.09%38.25M
17.06%239.42M
47.51%183.06M
63.23%120.39M
8.10%45.59M
7.93%204.54M
-18.83%124.1M
-Interest expense (Financial expense)
-24.70%194.5M
-33.86%131.32M
-30.50%91.1M
-20.31%43.63M
3.99%258.3M
8.20%198.56M
21.10%131.09M
-7.17%54.75M
-5.16%248.38M
-10.49%183.51M
-Interest Income (Financial expense)
19.77%-46.95M
19.39%-37.58M
21.85%-27.39M
20.48%-15.3M
24.54%-58.52M
21.53%-46.62M
12.63%-35.05M
-5.69%-19.24M
-6.33%-77.55M
-11.73%-59.4M
Research and development
-18.60%19.99M
-13.95%16.56M
-10.29%11.63M
-5.39%5.92M
-8.45%24.55M
7.16%19.24M
7.72%12.97M
180.75%6.26M
195.81%26.82M
--17.96M
Credit Impairment Loss
10.75%-88.65M
-201.94%-141.69M
-225.42%-89.04M
-56.32%-63.86M
-29.00%-99.33M
46.24%-46.93M
55.64%-27.36M
14.17%-40.85M
-256.30%-77M
-52.10%-87.28M
Asset Impairment Loss
70.82%-290.18M
62.45%-4.04M
51.80%-4.69M
1.20%-1.79M
-5,558.10%-994.53M
-24.43%-10.76M
-284.69%-9.74M
27.74%-1.81M
75.45%-17.58M
19.82%-8.65M
Other net revenue
88.55%-90.2M
-68.18%83.58M
-54.08%85.82M
-66.96%27.09M
-394.92%-787.54M
20.34%262.69M
20.70%186.9M
45.44%82M
54.70%267.04M
90.53%218.29M
Fair value change income
115.13%3.13M
2.55%3.23M
----
----
-36.37%-20.68M
-81.93%3.15M
-81.93%3.15M
----
-152.51%-15.16M
--17.43M
Invest income
-10.00%217.61M
-35.25%165.07M
-28.38%136.13M
-22.60%79.52M
2.01%241.79M
12.27%254.93M
22.09%190.06M
17.13%102.74M
70.36%237.03M
103.50%227.06M
-Including: Investment income associates
-14.61%315.68M
-26.50%228.18M
-20.81%179.97M
-9.17%100.21M
17.20%369.7M
33.55%310.43M
44.83%227.27M
42.41%110.34M
5.67%315.45M
29.98%232.45M
Asset deal income
-32.98%7.96M
48.53%10.04M
2.09%4.12M
-66.83%997.53K
-73.80%11.87M
-37.29%6.76M
-49.84%4.03M
69.31%3.01M
445.31%45.31M
67.65%10.78M
Other revenue
-18.27%59.93M
-8.23%50.96M
46.91%39.31M
-35.37%12.22M
-22.35%73.33M
-5.80%55.53M
-29.44%26.76M
11.32%18.91M
5.51%94.44M
-8.93%58.95M
Operating profit
163.80%1.51B
-0.82%1.33B
-2.36%926.5M
-19.28%439.14M
-76.76%573.48M
-26.25%1.34B
-26.74%948.86M
-5.61%544M
7.00%2.47B
16.54%1.82B
Add:Non operating Income
-31.61%20.08M
-38.33%13.51M
-21.44%10.19M
-19.42%6.57M
20.09%29.37M
139.75%21.91M
118.95%12.97M
137.14%8.15M
96.22%24.45M
-0.28%9.14M
Less:Non operating expense
-12.72%23.89M
196.50%29.34M
380.57%18.58M
287.87%7.38M
46.77%27.37M
-14.78%9.89M
-58.81%3.87M
46.00%1.9M
150.01%18.65M
189.62%11.61M
Total profit
162.22%1.51B
-2.86%1.32B
-4.16%918.11M
-20.34%438.33M
-76.73%575.47M
-25.49%1.36B
-25.83%957.97M
-4.88%550.25M
7.02%2.47B
16.00%1.82B
Less:Income tax cost
12.47%380.67M
14.37%298.26M
9.37%205.52M
-12.94%90.65M
-34.25%338.47M
-29.56%260.79M
-28.35%187.91M
-11.50%104.13M
-4.56%514.74M
5.95%370.26M
Net profit
376.09%1.13B
-6.96%1.02B
-7.46%712.59M
-22.07%347.68M
-87.90%237M
-24.45%1.1B
-25.19%770.05M
-3.19%446.12M
10.54%1.96B
18.87%1.45B
Net profit from continuing operation
376.09%1.13B
-6.96%1.02B
-7.46%712.59M
-22.07%347.68M
-87.90%237M
-24.45%1.1B
-25.19%770.05M
-3.19%446.12M
10.54%1.96B
18.87%1.45B
Less:Minority Profit
98.13%-7.58M
106.72%62.28M
75.73%46.69M
-65.69%19.68M
-212.88%-405.49M
-88.44%30.13M
-86.66%26.57M
-41.85%57.35M
26.03%359.23M
51.20%260.53M
Net profit of parent company owners
76.80%1.14B
-10.18%957.12M
-10.43%665.91M
-15.63%328M
-59.83%642.49M
-10.43%1.07B
-10.45%743.49M
7.33%388.77M
7.57%1.6B
13.56%1.19B
Earning per share
Basic earning per share
77.39%2.04
-9.95%1.72
-10.45%1.2
-15.71%0.59
-59.93%1.15
-10.75%1.91
-10.07%1.34
7.69%0.7
7.49%2.87
13.83%2.14
Diluted earning per share
77.39%2.04
-9.95%1.72
-10.45%1.2
-15.71%0.59
-59.93%1.15
-10.75%1.91
-10.07%1.34
7.69%0.7
7.49%2.87
13.83%2.14
Other composite income
112.68%1.97M
-160.55%-36.25K
-160.55%-36.25K
-27,699.43%-15.54M
-41.32%-13.91K
-41.32%-13.91K
100.24%56.31K
-107.43%-9.85K
Other composite income of parent company owners
112.59%1.17M
-160.55%-36.25K
-160.55%-36.25K
----
-24,583.97%-9.32M
-41.32%-13.91K
-41.32%-13.91K
----
100.27%38.05K
-107.43%-9.85K
Other composite income of minority owners
112.82%798.02K
----
----
----
-34,191.12%-6.23M
----
----
----
100.20%18.26K
----
Total composite income
410.39%1.13B
-6.96%1.02B
-7.46%712.56M
-22.07%347.68M
-88.69%221.46M
-24.45%1.1B
-25.19%770.04M
-3.19%446.12M
12.02%1.96B
18.86%1.45B
Total composite income of parent company owners
79.59%1.14B
-10.18%957.08M
-10.44%665.87M
-15.63%328M
-60.41%633.18M
-10.43%1.07B
-10.45%743.47M
7.34%388.77M
8.59%1.6B
13.54%1.19B
Total composite income of minority owners
98.35%-6.78M
106.72%62.28M
75.73%46.69M
-65.69%19.68M
-214.60%-411.72M
-88.44%30.13M
-86.66%26.57M
-41.85%57.35M
30.32%359.25M
51.20%260.53M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Auditor
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
PwC Zhongtian Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023
Total operating revenue -1.29%73.42B-2.38%55.12B-2.62%36.8B-4.17%18.29B-1.46%74.38B-0.21%56.47B-1.57%37.79B2.16%19.09B2.77%75.48B3.61%56.59B
Operating revenue -1.29%73.42B-2.38%55.12B-2.62%36.8B-4.17%18.29B-1.46%74.38B-0.21%56.47B-1.57%37.79B2.16%19.09B2.77%75.48B3.61%56.59B
Other operating revenue -9.31%637.52M-----15.25%350.49M----11.00%703M----8.14%413.53M-----14.71%633.35M----
Total operating cost -1.65%71.81B-2.73%53.87B-2.88%35.96B-4.01%17.88B-0.35%73.02B0.73%55.38B-0.60%37.02B2.54%18.63B2.76%73.28B3.41%54.98B
Operating cost -0.84%65.58B-1.95%49.34B-2.31%32.86B-3.62%16.4B-0.45%66.13B0.56%50.33B-0.87%33.64B2.80%17.02B2.96%66.43B3.53%50.05B
Operating tax surcharges -1.75%186.31M-2.14%138.89M-2.74%93.37M-1.70%44.71M0.77%189.63M2.00%141.93M6.00%96M6.61%45.48M-2.14%188.18M-2.31%139.15M
Operating expense -9.58%4.85B-9.87%3.55B-7.78%2.44B-7.26%1.17B0.65%5.36B2.52%3.94B1.47%2.64B0.11%1.26B1.01%5.33B2.58%3.84B
Administration expense -6.80%1B-9.09%703.4M-8.46%466.64M-12.28%220.75M-2.88%1.07B-4.39%773.75M-3.94%509.77M-5.12%251.65M-2.03%1.11B3.49%809.31M
Financial expense -23.58%182.96M-34.48%119.93M-30.91%83.18M-16.09%38.25M17.06%239.42M47.51%183.06M63.23%120.39M8.10%45.59M7.93%204.54M-18.83%124.1M
-Interest expense (Financial expense) -24.70%194.5M-33.86%131.32M-30.50%91.1M-20.31%43.63M3.99%258.3M8.20%198.56M21.10%131.09M-7.17%54.75M-5.16%248.38M-10.49%183.51M
-Interest Income (Financial expense) 19.77%-46.95M19.39%-37.58M21.85%-27.39M20.48%-15.3M24.54%-58.52M21.53%-46.62M12.63%-35.05M-5.69%-19.24M-6.33%-77.55M-11.73%-59.4M
Research and development -18.60%19.99M-13.95%16.56M-10.29%11.63M-5.39%5.92M-8.45%24.55M7.16%19.24M7.72%12.97M180.75%6.26M195.81%26.82M--17.96M
Credit Impairment Loss 10.75%-88.65M-201.94%-141.69M-225.42%-89.04M-56.32%-63.86M-29.00%-99.33M46.24%-46.93M55.64%-27.36M14.17%-40.85M-256.30%-77M-52.10%-87.28M
Asset Impairment Loss 70.82%-290.18M62.45%-4.04M51.80%-4.69M1.20%-1.79M-5,558.10%-994.53M-24.43%-10.76M-284.69%-9.74M27.74%-1.81M75.45%-17.58M19.82%-8.65M
Other net revenue 88.55%-90.2M-68.18%83.58M-54.08%85.82M-66.96%27.09M-394.92%-787.54M20.34%262.69M20.70%186.9M45.44%82M54.70%267.04M90.53%218.29M
Fair value change income 115.13%3.13M2.55%3.23M---------36.37%-20.68M-81.93%3.15M-81.93%3.15M-----152.51%-15.16M--17.43M
Invest income -10.00%217.61M-35.25%165.07M-28.38%136.13M-22.60%79.52M2.01%241.79M12.27%254.93M22.09%190.06M17.13%102.74M70.36%237.03M103.50%227.06M
-Including: Investment income associates -14.61%315.68M-26.50%228.18M-20.81%179.97M-9.17%100.21M17.20%369.7M33.55%310.43M44.83%227.27M42.41%110.34M5.67%315.45M29.98%232.45M
Asset deal income -32.98%7.96M48.53%10.04M2.09%4.12M-66.83%997.53K-73.80%11.87M-37.29%6.76M-49.84%4.03M69.31%3.01M445.31%45.31M67.65%10.78M
Other revenue -18.27%59.93M-8.23%50.96M46.91%39.31M-35.37%12.22M-22.35%73.33M-5.80%55.53M-29.44%26.76M11.32%18.91M5.51%94.44M-8.93%58.95M
Operating profit 163.80%1.51B-0.82%1.33B-2.36%926.5M-19.28%439.14M-76.76%573.48M-26.25%1.34B-26.74%948.86M-5.61%544M7.00%2.47B16.54%1.82B
Add:Non operating Income -31.61%20.08M-38.33%13.51M-21.44%10.19M-19.42%6.57M20.09%29.37M139.75%21.91M118.95%12.97M137.14%8.15M96.22%24.45M-0.28%9.14M
Less:Non operating expense -12.72%23.89M196.50%29.34M380.57%18.58M287.87%7.38M46.77%27.37M-14.78%9.89M-58.81%3.87M46.00%1.9M150.01%18.65M189.62%11.61M
Total profit 162.22%1.51B-2.86%1.32B-4.16%918.11M-20.34%438.33M-76.73%575.47M-25.49%1.36B-25.83%957.97M-4.88%550.25M7.02%2.47B16.00%1.82B
Less:Income tax cost 12.47%380.67M14.37%298.26M9.37%205.52M-12.94%90.65M-34.25%338.47M-29.56%260.79M-28.35%187.91M-11.50%104.13M-4.56%514.74M5.95%370.26M
Net profit 376.09%1.13B-6.96%1.02B-7.46%712.59M-22.07%347.68M-87.90%237M-24.45%1.1B-25.19%770.05M-3.19%446.12M10.54%1.96B18.87%1.45B
Net profit from continuing operation 376.09%1.13B-6.96%1.02B-7.46%712.59M-22.07%347.68M-87.90%237M-24.45%1.1B-25.19%770.05M-3.19%446.12M10.54%1.96B18.87%1.45B
Less:Minority Profit 98.13%-7.58M106.72%62.28M75.73%46.69M-65.69%19.68M-212.88%-405.49M-88.44%30.13M-86.66%26.57M-41.85%57.35M26.03%359.23M51.20%260.53M
Net profit of parent company owners 76.80%1.14B-10.18%957.12M-10.43%665.91M-15.63%328M-59.83%642.49M-10.43%1.07B-10.45%743.49M7.33%388.77M7.57%1.6B13.56%1.19B
Earning per share
Basic earning per share 77.39%2.04-9.95%1.72-10.45%1.2-15.71%0.59-59.93%1.15-10.75%1.91-10.07%1.347.69%0.77.49%2.8713.83%2.14
Diluted earning per share 77.39%2.04-9.95%1.72-10.45%1.2-15.71%0.59-59.93%1.15-10.75%1.91-10.07%1.347.69%0.77.49%2.8713.83%2.14
Other composite income 112.68%1.97M-160.55%-36.25K-160.55%-36.25K-27,699.43%-15.54M-41.32%-13.91K-41.32%-13.91K100.24%56.31K-107.43%-9.85K
Other composite income of parent company owners 112.59%1.17M-160.55%-36.25K-160.55%-36.25K-----24,583.97%-9.32M-41.32%-13.91K-41.32%-13.91K----100.27%38.05K-107.43%-9.85K
Other composite income of minority owners 112.82%798.02K-------------34,191.12%-6.23M------------100.20%18.26K----
Total composite income 410.39%1.13B-6.96%1.02B-7.46%712.56M-22.07%347.68M-88.69%221.46M-24.45%1.1B-25.19%770.04M-3.19%446.12M12.02%1.96B18.86%1.45B
Total composite income of parent company owners 79.59%1.14B-10.18%957.08M-10.44%665.87M-15.63%328M-60.41%633.18M-10.43%1.07B-10.45%743.47M7.34%388.77M8.59%1.6B13.54%1.19B
Total composite income of minority owners 98.35%-6.78M106.72%62.28M75.73%46.69M-65.69%19.68M-214.60%-411.72M-88.44%30.13M-86.66%26.57M-41.85%57.35M30.32%359.25M51.20%260.53M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified opinion------Unqualified opinion------Unqualified opinion--
Auditor Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------PwC Zhongtian Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More